When the Bato Breaks: Diabetic Kidney Disease and the Filipino-American Silent Crisis
When the Bato Breaks: Diabetic Kidney Disease and the Filipino-American Silent Crisis
The kidneys are the body's most faithful workers — and the last to complain. For Filipino Americans living with diabetes and high blood pressure, the silence is the danger.
The kidneys do not send press releases. There is no pain, no visible swelling, no alarm — just a slow, quiet erosion happening inside the body while life goes on around it. By the time most people find out something is wrong, the damage is already significant. For Filipino Americans, who carry among the highest rates of Type 2 diabetes and hypertension in the Asian-American community, the kidneys are ground zero of a crisis that too few are talking about.
This is the second article in PinoyBuilt's Kalusugan series. If you read The Filipino Constellation, you already know that diabetes, hypertension, and heart disease form a cluster in the Fil-Am body — each one feeding the others. Today we go deeper into one specific organ that sits at the center of that constellation: the bato.
According to the Philippine Society of Nephrology, approximately one Filipino develops chronic renal failure every hour — roughly 120 new cases per million population per year. That number is not slowing down. The primary drivers: uncontrolled diabetes and hypertension — the same two conditions disproportionately affecting Filipino Americans in the United States.
💬 Please comment below ↓
Bato BAH-toh
Meaning: Stone; rock; kidney (anatomical). In everyday Tagalog, bato refers to a literal stone — but in medical and anatomical usage, it is the word for the kidney itself. The root meaning matters: the bato is the hardest-working, most durable organ in the body. Like a stone, it filters, endures, and holds the weight of everything else. Until it doesn't.
What the Bato Actually Does
Most people know the kidneys filter waste. What most people do not know is the scale of that work. Each kidney contains roughly one million tiny filtering units called nephrons. Every 24 hours, your kidneys filter approximately 50 gallons of blood — extracting waste, regulating blood pressure, controlling fluid balance, producing hormones that signal bone marrow to make red blood cells, and maintaining the precise chemical environment your heart, brain, and muscles depend on.
They do all of this silently. The kidneys have no pain receptors in the filtering tissue itself. You can lose 50 to 60 percent of your kidney function and feel nothing. This is why chronic kidney disease (CKD) is called a silent disease — and why diabetic kidney disease (DKD), the form caused by long-term high blood sugar, is so dangerous. The window to act is wide open for years. And most people never open it.
Why Filipino Americans Are at the Front of the Risk Line
Diabetic kidney disease begins with a single mechanism: sustained high blood sugar damages the small blood vessels inside the nephrons. Over time, the filters become leaky — and instead of keeping vital proteins inside the blood where they belong, the kidneys start letting them spill into the urine. This is called albuminuria or proteinuria, and it is both a symptom of damage and an accelerant of further damage.
Filipino Americans are at elevated risk for DKD for the same reasons they are at elevated risk for the Filipino Constellation writ large: a genetic predisposition to insulin resistance, a traditional diet high in sodium and refined carbohydrates, a cultural aversion to seeking medical care early, and decades of structural barriers to healthcare access — particularly for the working-class Fil-Am families who built this country from the ground up.
Add hypertension to the equation — another condition that disproportionately affects Filipino Americans — and the kidney damage accelerates. High blood pressure scars the kidney's blood vessels independently of blood sugar. When both are elevated simultaneously, as they frequently are in our community, the kidneys face a two-front assault.
Reading the Numbers: What ACR and PCR Actually Tell You
Most people who get bloodwork done know their A1c. Fewer know their ACR. Almost nobody knows their PCR. These are the two numbers that tell you what is happening inside your kidneys right now — and they should be as familiar to any diabetic Filipino American as their glucose reading.
ACR (Albumin-to-Creatinine Ratio) measures how much albumin — a key blood protein — is leaking into your urine. The normal range is below 30 ug/mg. Between 30 and 300 is called microalbuminuria, an early warning. Above 300 ug/mg is macroalbuminuria — classified as severely increased albuminuria (A3 category by KDIGO international standards). At that level, the kidneys are under significant stress, and the risk of progression to kidney failure is measurably elevated.
PCR (Protein-to-Creatinine Ratio) captures total protein leakage, not just albumin. Normal is below 0.068 mg/mg. A PCR of 0.2 is already abnormal. A PCR in the range of 2.652 mg/mg — which appears in the case study below — represents nephrotic-range proteinuria: the kidneys are hemorrhaging protein at a rate that, if unchecked, accelerates kidney failure and elevates cardiovascular risk simultaneously.
A Case Study: The Numbers From a Real Fil-Am Kitchen Table
The following profile is drawn from a real patient — a 1.5-generation Filipino-American man in his late fifties, based in Northern California — shared with his knowledge and consent for this article. The clinical picture is presented here because it is not unusual. It is, in fact, representative of thousands of Fil-Am men and women across the country who are managing these conditions right now, mostly in silence.
🩺 ANONYMIZED CASE STUDY — NorCal Fil-Am, Late 50s, Male
The case above is real. It is mine. I am the Fil-Am man in his late fifties in Northern California. I chose to share these numbers publicly because hiding them would defeat the purpose of this series. The A1c at 11.2 percent two years ago was a crisis. The A1c at 7.7 percent today — with insulin discontinued — is a hard-won gain. But the kidney numbers, the blood pressure, the proteinuria: those are still flashing red. I am not writing this from the other side of recovery. I am writing it from the middle. And if you see your own numbers reflected here, that is exactly why I published them. — J.F.R. Perseveranda
This case illustrates the two-lane collision: strong progress on glucose control, simultaneous stress on the kidneys and cardiovascular system. The A1c improvement is real and meaningful. But the kidney damage does not pause while the glucose numbers improve. Both lanes need attention at the same time.
The New Science: What SGLT2 Inhibitors Mean for Diabetic Kidney Disease
For most of the history of diabetic kidney disease management, the playbook was: control your blood sugar, control your blood pressure, and slow the decline. That playbook has not changed — but a new chapter has been added.
On January 20, 2026, JAMA Internal Medicine published a landmark comparative study by Jensen and colleagues out of Denmark examining SGLT2 inhibitors versus GLP-1 receptor agonists in patients with Type 2 diabetes over a five-year follow-up period. The findings are significant: SGLT2 inhibitors were associated with a 19% lower risk of chronic kidney disease and 12% fewer acute kidney injury events compared to GLP-1 receptor agonists.
This matters for our community. SGLT2 inhibitors — medications like empagliflozin (Jardiance) and dapagliflozin (Farxiga) — work in part by reducing pressure inside the kidney's filtering units, directly addressing one of the primary mechanisms by which diabetes damages the nephron over time. They are not a cure, and they are not appropriate for everyone. But for diabetic Filipino Americans with early-stage kidney stress — elevated ACR, borderline PCR, blood pressure control issues — the conversation with your doctor about SGLT2 inhibitors is worth having.
The Philippine Society of Nephrology convened its 46th Annual Convention in April 2026 at the EDSA Shangri-La Manila — the 55th year of their organization — under the theme Emerald Renaissance. Nephrology in the Philippines is moving. The science is advancing. And the Filipino diaspora in the United States deserves access to that same level of conversation with their providers.
The Weight of Pagtitiis
Pagtitiis. The word does not translate cleanly into English. Endurance. Patience. The act of bearing difficulty without complaint, because complaining is weakness, and weakness is something Filipinos do not show. It is woven into how we were raised, how our parents survived, how our grandparents built something from nothing in a country that was not always welcoming.
It is also, in the context of kidney disease, a cultural liability that is quietly killing our community.
Kaya mo yan. You can handle it. Push through. Don't make a big deal. These are the phrases that keep Filipino Americans from the doctor's office. The phrases that turn a manageable ACR into an irreversible kidney failure. The phrases that mean a man in his late fifties doesn't find out his kidneys are under siege until the numbers are already in the red.
Pagtitiis is not wrong as a value. It has carried our people through colonization, migration, displacement, and grief. But pagtitiis applied to a silent disease — a disease with no pain, no warning, no drama — becomes something else. It becomes permission to not look. And what you don't look at cannot be treated.
The Filipino cultural value of endurance — pagtitiis — is a strength in many arenas of life. But applied to a silent disease, it becomes permission to not look. And what you don't look at cannot be treated.
The kidney does not ask for your attention. It just keeps filtering, keeps enduring, keeps losing ground — quietly, faithfully, exactly the way it was built to do. Until it can't anymore. By then, the only remaining option is a dialysis machine, three times a week, four hours a session, for the rest of your life. Or a transplant, if you are lucky enough to find a match in time.
Ask for the ACR. Ask for the PCR. It is a line on a lab slip. It takes ten seconds to add to your bloodwork order. Do it.
Final Thoughts: What You Can Do Right Now
This is not a hopeless story. The case study above is proof of that. An A1c that dropped from 11.2 to 7.7 percent without insulin — through dietary discipline and sheer stubbornness — is proof that the trajectory can be changed. Early-stage diabetic kidney disease, even at macroalbuminuria levels, is not necessarily a one-way road. The window exists. The science is there. The action steps are clear:
Know your numbers. At your next lab visit, request an ACR and PCR alongside your standard bloodwork. If your doctor doesn't routinely order them for you, ask specifically. These numbers are the kidney's report card.
Control the two primary levers. Glucose and blood pressure. They are not separate problems — they are the same problem expressed in two different systems. Bring your A1c below 7.0 percent. Get your BP below 130/80. Every point of improvement on both measures reduces the rate of kidney damage.
Ask about SGLT2 inhibitors. If you are diabetic and your doctor has not discussed SGLT2 inhibitors with you in the context of kidney protection, bring this article. The 2026 JAMA data is a starting point for a real conversation.
Hydrate. Reduce sodium. The Filipino diet — adobo, bagoong, canned goods, processed meats — is among the highest-sodium diets in the world. Sodium raises blood pressure, which damages the kidneys. This one is hard. It is also real.
You are not alone in this. You are part of a community of 4.6 million Filipino Americans across the United States, many of whom are carrying these same numbers, living in the same silence. PinoyBuilt exists in part to break that silence — to say the things out loud that we were raised not to say. The bato needs you to speak up for it. Because it will not speak up for itself.
- Jensen, M.L. et al. "SGLT2 Inhibitors vs. GLP-1 Receptor Agonists and Risk of Kidney Outcomes in Type 2 Diabetes." JAMA Internal Medicine, January 20, 2026.
- Philippine Society of Nephrology (PSN). 46th Annual Convention — Emerald Renaissance, April 21–25, 2026. EDSA Shangri-La, Mandaluyong City. 55th anniversary year.
- Kidney Disease: Improving Global Outcomes (KDIGO). kdigo.org — CKD classification framework (ACR/GFR categories, A1–A3 albuminuria staging).
- National Kidney Foundation. "About Chronic Kidney Disease." kidney.org
- American Diabetes Association. "Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes." Diabetes Care, current edition. diabetesjournals.org
- PinoyBuilt Kalusugan Series, No. 1: The Filipino Constellation: Why Diabetes, High Blood Pressure, and Heart Disease Hit Fil-Am Families So Hard.
Help Us Become the #1 Filipino-American Media Platform in the U.S.
PinoyBuilt is built by the community, for the community. If this article meant something to you — if it made you proud, informed, or connected — we need your help to reach every kababayan out there.
💬 Drop a comment below — tell us your numbers, share your story, ask your questions.
📲 Text this article to a friend, a tita, a teammate — anyone who needs to see this.
📣 Share it on your socials — every share brings us closer.
4.6 million Filipinos in the U.S. One platform telling our stories. Salamat, kababayan.
FOUNDER & EDITOR
J.F.R. Perseveranda
J.F. (Jonjo) left the Philippines at age nine, spending a lifetime bridging the gap between his Marikina roots and his Chicago/Vallejo upbringing. A proud Hogan Spartan from East Vallejo and resident of the Bay Area, he founded PinoyBuilt not just as a digital archive, but as a cultural compass for his three children to navigate their heritage, language, and identity with Pinoy Pride.
Mary the force be with you, and with me. 💪🏽🙏🏽⚔️
ReplyDelete